StockWatch
·
Biotechnology: Pharmaceutical Preparations
ESOPMay 27, 2026, 07:31 AM

Context Therapeutics Grants 146,000 Stock Options to New Employee

AI Summary

Context Therapeutics Inc. announced it granted a non-qualified stock option award to purchase 146,000 shares of its common stock to a new employee as an inducement for accepting employment. The options were granted on May 26, 2026, with an exercise price of $2.63 per share, and vest over four years. Additionally, the company will present at the Jefferies Global Healthcare Conference on June 3, 2026.

Key Highlights

  • Granted 146,000 non-qualified stock options to a new employee.
  • Options granted on May 26, 2026, with an exercise price of $2.63 per share.
  • Options vest over four years, with one-fourth on the first anniversary and monthly thereafter.
  • Options have a 10-year term.
  • Context Therapeutics will present at the Jefferies Global Healthcare Conference on June 3, 2026.